Immunology in Diabetes '84
The conference "Immunology in Diabetes '84", which was held in Rome from 15-17 March, 1984 , attracted not only an unexpected number of contributions (more than 150 abstracts were submitted) but also an equally unexpected number of participants from all over the world.
In contrast to previous conferences on aspects of immunology in ,diabetes held in Brussels (1973) , Copenhagen (1975) , Edinburgh (1978) , Luxembourg (1982) and London (1983) , which featured invited speakers only, the approach to the 1984 conference was to allow interested workers in the field to submit abstracts to be selected by a Scientific Committee for either oral or poster presentation. The large number of studies submitted for the conference may be taken as a sign of an escalating interest in understanding immunological phenomena as they relate to both the aetiology and the pathogenesis of diabetes and the effects of diabetes on important immune functions. Hence the study of immunology in diabetes is no longer restricted to a small group of diabetologists. There also seems to be an increasing interest in immunological aspects of diabetes being revealed by both basic and clinical investigators in other areas of research. The character of the "Immunology in Diabe, tes '84" conference as a forum for presenting original studies, as opposed to polished reviews, made it possible to invite the participants to submit their work, provided it had not been published already, to be reviewed by an Editorial Committee which included the Editor-in-Chief of Diabetologia.
Immunology in diabetes is all too broad a designation. At the conference in Rome subjects as widely divergent as the association between insulin-dependent diabetes and c, omponents including transplantation antigens or complement factors coded for in the major histocompatibiliity complex, and the possible influence of environmental factors (such as viruses) or autoimmune phenomena on the pathogenesis of insulin-dependent diabetes were covered. These factors also were studied appropriately in experimental animals with spontaneous diabetes, such as the BB rat, the non-obese diabetic mouse and even the db/db and ob/ob mouse, as well as in animals with diabetes induced by viruses or chemical agents.
The indications that autoimmune mechanisms occur against a background of certain immune-response genes have led not only to major efforts to detect insulin-dependent diabetes before the classical symptoms appear but also to studies directed at interfering with the function of the immune system in attempts to halt the destruction of fl cells. The continuous development of new pharmaceutical insulin preparations continues to attract interest in efforts to understand the immune response against injected insulin and how it may relate to the metabolic control of the patients. This question still remains to be solved. The action of insulin is being studied by immunological means also, and the physiology of the insulin receptor function eventually may be resolved. Patients forming autoantibodies against the insulin receptor have been most informative in this respect. Finally, the disappearance of the fl cells from the pancreas of insulin-dependent diabetic patients has resulted in attempts to replace the missing /3 cells by means of organ transplantation. "Immunology in Diabetes '84" therefore also included transplantation immunology in man, as well as in experimental animals.
Our impression is that the original manuscripts chosen for publication are representative of the 150 communications presented at the meeting. The following collection of studies is thus not an attempt to summarize the state-of-the-art of immunology in diabetes in 1984, nor is it a synopsis of the wealth of information that was relayed to the 300 participants fortunate enough to attend the conference. It represents, rather, a selection of the most original contributions, which, although admittedly not subjected to the formal review procedure normally employed by Diabetologia, were reviewed and chosen by the Editorial Committee for publication in this Supplement. The merit of these contributions thus lies not only in their selection for presentation at the Rome conference but also in their being chosen for publication by an international jury of peers. We are confident, therefore, that the reader will find the following collection of short communications informative and useful and will now leave him to read and evaluate them critically. Hopefully, these papers will foster new ideas and further well-planned investigations, which in turn will increase our understanding of the immunology of diabetes to the benefit of patients and our comprehension of the possible means by which this disease may be prevented.
The Editorial Committee would like to express its gratitude to Novo Farmaceutici Italia for its generous support, which made possible the organization of the conference and the publication of this Supplement.
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